Sequential compression devices, while effective at reducing the incidence of venous thromboembolism when properly used, often have poor rates of compliance. Overall compliance in our patient ...
AUSTIN, Texas--(BUSINESS WIRE)--USA Compression Partners, LP (NYSE: USAC) (“USA Compression” or the “Partnership”) announced today its financial and operating results for fourth-quarter 2022.
Background: Sequential compression devices (SCDs) are commonly used for thromboprophylaxis in postoperative patients but compliance is often poor. We investigated causes for noncompliance, examining ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback